+ Follow CANADIAN CARDIOVASCULAR COLLABORATION Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 131590
[Title] => Results of study on heart drug disclosed
[Summary] => The risk of life-threatening heart problems and stroke can be significantly reduced by 20 percent with an anti-platelet medicine called clopidogrel.
This was revealed in a report on the international clinical trial called CURE (Cloridogrel in Unstable Angina to Prevent Recurrent Ischemic Events) which was published in the Aug. 16 issue of the New England Journal of Medicine.
[DatePublished] => 2001-08-27 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
CANADIAN CARDIOVASCULAR COLLABORATION
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 131590
[Title] => Results of study on heart drug disclosed
[Summary] => The risk of life-threatening heart problems and stroke can be significantly reduced by 20 percent with an anti-platelet medicine called clopidogrel.
This was revealed in a report on the international clinical trial called CURE (Cloridogrel in Unstable Angina to Prevent Recurrent Ischemic Events) which was published in the Aug. 16 issue of the New England Journal of Medicine.
[DatePublished] => 2001-08-27 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
August 27, 2001 - 12:00am